2021 Q3 Form 10-Q Financial Statement
#000156459021056248 Filed on November 10, 2021
Income Statement
| Concept | 2021 Q3 | 2021 Q2 | 2020 Q4 |
|---|---|---|---|
| Revenue | $8.124M | $2.218M | $5.150M |
| YoY Change | 23.95% | -83.43% | 54.65% |
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $4.831M | $6.339M | $3.110M |
| YoY Change | 50.5% | 91.51% | -2.2% |
| % of Gross Profit | |||
| Research & Development | $18.89M | $18.38M | $14.97M |
| YoY Change | 44.76% | 71.43% | 27.4% |
| % of Gross Profit | |||
| Depreciation & Amortization | $209.0K | $227.0K | $200.0K |
| YoY Change | 22.94% | 33.53% | 33.33% |
| % of Gross Profit | |||
| Operating Expenses | $23.72M | $24.72M | $18.07M |
| YoY Change | 45.98% | 76.17% | 21.03% |
| Operating Profit | -$15.60M | ||
| YoY Change | |||
| Interest Expense | -$52.00K | $172.0K | $590.0K |
| YoY Change | -108.13% | -87.89% | 210.53% |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$52.00K | ||
| YoY Change | |||
| Pretax Income | -$15.65M | -$22.33M | -$12.34M |
| YoY Change | 72.78% | 10531.43% | 8.15% |
| Income Tax | -$205.0K | -$217.0K | -$10.00K |
| % Of Pretax Income | |||
| Net Earnings | -$15.45M | -$22.11M | -$12.32M |
| YoY Change | 74.42% | 12533.71% | 8.26% |
| Net Earnings / Revenue | -190.12% | -996.8% | -239.22% |
| Basic Earnings Per Share | -$0.36 | ||
| Diluted Earnings Per Share | -$374.9K | -$512.9K | -$352.0K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 42.27M | ||
| Diluted Shares Outstanding | 42.27M |
Balance Sheet
| Concept | 2021 Q3 | 2021 Q2 | 2020 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $249.6M | $260.5M | $177.0M |
| YoY Change | 30.76% | 28.46% | 25.18% |
| Cash & Equivalents | $87.81M | $82.93M | $45.01M |
| Short-Term Investments | $161.8M | $177.6M | $132.0M |
| Other Short-Term Assets | $3.454M | $3.313M | $3.000M |
| YoY Change | 50.17% | 32.52% | 11.11% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | $3.235M | $2.919M | $1.822M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $256.3M | $266.8M | $181.8M |
| YoY Change | 31.58% | 28.87% | 25.48% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $7.228M | $7.412M | $3.554M |
| YoY Change | 90.21% | 118.0% | 114.1% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $811.0K | $544.0K | $500.0K |
| YoY Change | 62.2% | 81.33% | 150.0% |
| Total Long-Term Assets | $8.039M | $7.956M | $7.403M |
| YoY Change | 86.95% | 115.03% | 161.5% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $256.3M | $266.8M | $181.8M |
| Total Long-Term Assets | $8.039M | $7.956M | $7.403M |
| Total Assets | $264.4M | $274.7M | $189.2M |
| YoY Change | 32.77% | 30.38% | 28.09% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $3.085M | $3.278M | $3.000M |
| YoY Change | 40.23% | 104.88% | 20.0% |
| Accrued Expenses | $7.543M | $8.605M | $8.000M |
| YoY Change | 4.76% | 28.43% | 26.98% |
| Deferred Revenue | $2.202M | $3.642M | |
| YoY Change | -87.76% | ||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $12.86M | $14.98M | $14.78M |
| YoY Change | -23.93% | -29.0% | -65.93% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| Other Long-Term Liabilities | $2.558M | $2.746M | $3.100M |
| YoY Change | 1179.0% | 815.33% | 106.67% |
| Total Long-Term Liabilities | $2.558M | $2.746M | $3.100M |
| YoY Change | 1179.0% | 815.33% | -71.53% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $12.86M | $14.98M | $14.78M |
| Total Long-Term Liabilities | $2.558M | $2.746M | $3.100M |
| Total Liabilities | $15.41M | $17.73M | $17.83M |
| YoY Change | -9.86% | -17.16% | -68.0% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$331.8M | -$316.4M | -$278.5M |
| YoY Change | 24.66% | 22.95% | 11.55% |
| Common Stock | $443.1M | ||
| YoY Change | 32.31% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $248.9M | $257.0M | $171.4M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $264.4M | $274.7M | $189.2M |
| YoY Change | 32.77% | 30.38% | 28.09% |
Cashflow Statement
| Concept | 2021 Q3 | 2021 Q2 | 2020 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$15.45M | -$22.11M | -$12.32M |
| YoY Change | 74.42% | 12533.71% | 8.26% |
| Depreciation, Depletion And Amortization | $209.0K | $227.0K | $200.0K |
| YoY Change | 22.94% | 33.53% | 33.33% |
| Cash From Operating Activities | -$15.01M | -$13.07M | -$13.11M |
| YoY Change | 34.59% | 21.18% | -166.25% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$223.0K | -$913.0K | -$830.0K |
| YoY Change | -71.77% | 146.76% | 40.68% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $15.80M | $9.101M | $44.02M |
| YoY Change | -191.69% | -19.46% | -173.71% |
| Cash From Investing Activities | $15.58M | $8.188M | $43.20M |
| YoY Change | -186.38% | -25.16% | -171.62% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 4.758M | 112.0K | 50.00K |
| YoY Change | -100.67% | -99.82% | |
| NET CHANGE | |||
| Cash From Operating Activities | -15.01M | -13.07M | -13.11M |
| Cash From Investing Activities | 15.58M | 8.188M | 43.20M |
| Cash From Financing Activities | 4.758M | 112.0K | 50.00K |
| Net Change In Cash | 5.326M | -4.775M | 30.14M |
| YoY Change | -118.25% | -71.18% | -330.08% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$15.01M | -$13.07M | -$13.11M |
| Capital Expenditures | -$223.0K | -$913.0K | -$830.0K |
| Free Cash Flow | -$14.78M | -$12.16M | -$12.28M |
| YoY Change | 42.7% | 16.72% | -160.26% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2020Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P1Y6M | |
| CY2021Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y9M7D | |
| CY2020Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y7M20D | |
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y8M8D | ||
| us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y9M14D | ||
| CY2020Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
45357000 | |
| CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-278492000 | |
| CY2020Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-990000 | |
| CY2021Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-128000 | |
| us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-988000 | ||
| CY2021Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-15650000 | |
| CY2020Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-9058000 | |
| CY2021Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-205000 | |
| CY2020Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-203000 | |
| CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8855000 | |
| CY2021Q3 | xene |
Net Income Loss Available To Preferred Stockholders Basic
NetIncomeLossAvailableToPreferredStockholdersBasic
|
362000 | |
| CY2020Q3 | xene |
Net Income Loss Available To Preferred Stockholders Basic
NetIncomeLossAvailableToPreferredStockholdersBasic
|
250000 | |
| CY2021Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-15083000 | |
| CY2020Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-8605000 | |
| CY2021Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.36 | |
| CY2020Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.25 | |
| dei |
Amendment Flag
AmendmentFlag
|
false | ||
| CY2020Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
1016000 | |
| CY2020Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
7732000 | |
| CY2020Q3 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
6554000 | |
| us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
14700000 | ||
| CY2020Q3 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
475000 | |
| dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
Z4 | ||
| dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
BC | ||
| dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
| CY2020Q4 | us-gaap |
Preferred Stock No Par Value
PreferredStockNoParValue
|
||
| CY2021Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
87809000 | |
| CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
| CY2020Q4 | us-gaap |
Common Stock No Par Value
CommonStockNoParValue
|
||
| dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
| dei |
City Area Code
CityAreaCode
|
604 | ||
| dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
| dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
V5G 4W8 | ||
| dei |
Local Phone Number
LocalPhoneNumber
|
484-3300 | ||
| dei |
Security12b Title
Security12bTitle
|
Common Shares, without par value | ||
| dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Burnaby | ||
| dei |
Trading Symbol
TradingSymbol
|
XENE | ||
| dei |
Entity File Number
EntityFileNumber
|
001-36687 | ||
| dei |
Entity Address Country
EntityAddressCountry
|
CA | ||
| dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
98-0661854 | ||
| CY2020 | us-gaap |
Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
|
Unlimited | |
| CY2020 | us-gaap |
Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
|
Unlimited | |
| CY2021Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P5Y9M | |
| CY2020Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P1Y6M | |
| dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
200-3650 Gilmore Way | ||
| CY2021Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3454000 | |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
171355000 | |
| CY2021Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
686000 | |
| CY2020Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
3050000 | |
| CY2020Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
35012125 | |
| CY2020Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
35012125 | |
| CY2021Q3 | us-gaap |
Assets Current
AssetsCurrent
|
256314000 | |
| CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
17831000 | |
| CY2021Q3 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
3235000 | |
| CY2021Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
2558000 | |
| CY2021Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
2967000 | |
| CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
189186000 | |
| CY2020Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
1016000 | |
| CY2021Q3 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
161816000 | |
| CY2021Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
12856000 | |
| CY2021Q3 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
811000 | |
| CY2020Q4 | us-gaap |
Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
|
523000 | |
| CY2021Q3 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
2202000 | |
| CY2020Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
3642000 | |
| CY2020Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
397748000 | |
| CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15445000 | |
| CY2020Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
102456000 | |
| CY2020Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
14000 | |
| CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
187978000 | |
| us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-372000 | ||
| us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-9655000 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
12.41 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
7.46 | ||
| CY2021Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
41193267 | |
| CY2020Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
34994944 | |
| CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
248939000 | |
| us-gaap |
Profit Loss
ProfitLoss
|
-53318000 | ||
| us-gaap |
Profit Loss
ProfitLoss
|
-16514000 | ||
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
636000 | ||
| us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
442000 | ||
| us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
216000 | ||
| us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-240000 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
4067000 | ||
| us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
451000 | ||
| xene |
Proceeds From Issuance Of Common Shares And Pre Funded Warrants Net Of Issuance Costs
ProceedsFromIssuanceOfCommonSharesAndPreFundedWarrantsNetOfIssuanceCosts
|
123345000 | ||
| xene |
Proceeds From Issuance Of Common Shares And Pre Funded Warrants Net Of Issuance Costs
ProceedsFromIssuanceOfCommonSharesAndPreFundedWarrantsNetOfIssuanceCosts
|
102456000 | ||
| CY2020Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-175000 | |
| CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
189298000 | |
| CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8855000 | |
| CY2020Q3 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
1580000 | |
| CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
182023000 | |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
171355000 | |
| CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15764000 | |
| CY2021Q1 | xene |
Adjustments To Additional Paid In Capital Common Shares And Prefunded Warrants Issued
AdjustmentsToAdditionalPaidInCapitalCommonSharesAndPrefundedWarrantsIssued
|
118615000 | |
| CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
1965000 | |
| CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
276277000 | |
| CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-22109000 | |
| CY2021Q2 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
2704000 | |
| CY2021Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
111000 | |
| CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
256983000 | |
| CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15445000 | |
| CY2021Q3 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
4730000 | |
| CY2021Q3 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
2643000 | |
| CY2021Q3 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
28000 | |
| us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-288000 | ||
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
7312000 | ||
| us-gaap |
Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
|
-451000 | ||
| us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
-72000 | ||
| us-gaap |
Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
|
228000 | ||
| us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
-988000 | ||
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
940000 | ||
| us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
490000 | ||
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-787000 | ||
| us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-1440000 | ||
| us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
37000 | ||
| us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
85750000 | ||
| CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
236200 | |
| CY2020Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
15100000 | |
| xene |
Increase In Operating Lease Liability And Accounts Receivable Related To Lease Incentives Claimed In The Period
IncreaseInOperatingLeaseLiabilityAndAccountsReceivableRelatedToLeaseIncentivesClaimedInThePeriod
|
493000 | ||
| CY2021Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-331810000 | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
-53318000 | ||
| us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.54%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2.</span></p></td> <td valign="top"> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Basis of presentation:</p></td></tr></table></div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These consolidated financial statements are presented in U.S. dollars.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has one wholly-owned subsidiary as of September 30, 2021 Xenon Pharmaceuticals USA Inc., which was incorporated in Delaware on December 2, 2016.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These unaudited interim consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All intercompany transactions and balances have been eliminated on consolidation. </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited interim consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) and pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) for interim financial information. Accordingly, these consolidated financial statements do not include all of the information and footnotes required for complete consolidated financial statements and should be read in conjunction with the audited consolidated financial statements and notes for the year ended December 31, 2020 and included in the Company’s 2020 Annual Report on Form 10-K filed with the SEC and with the securities commissions in British Columbia, Alberta and Ontario on March 1, 2021.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;margin-left:4.54%;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These unaudited interim consolidated financial statements reflect all adjustments, consisting of normal recurring adjustments, which, in the opinion of management, are necessary for a fair presentation of results for the interim periods presented. The results of operations for the three and nine month periods ended September 30, 2021 and 2020 are not necessarily indicative of results that can be expected for a full year. These unaudited interim consolidated financial statements follow the same significant accounting policies as those described in the notes to the audited consolidated financial statements of the Company included in the Company’s 2020 Annual Report on Form 10-K for the year ended December 31, 2020, with the exception of the policy described in note 3 below.</p> | ||
| CY2021Q3 | us-gaap |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P5Y | |
| us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
411000 | ||
| us-gaap |
Variable Lease Cost
VariableLeaseCost
|
404000 | ||
| CY2020Q3 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0375 | |
| CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
203000 | |
| CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
697000 | |
| CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
571000 | |
| CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
571000 | |
| CY2021Q3 | xene |
Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
|
1428000 | |
| CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
3470000 | |
| CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
226000 | |
| CY2021Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
3244000 | |
| CY2021Q3 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
3085000 | |
| CY2020Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
3041000 | |
| CY2021Q3 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
3383000 | |
| CY2020Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
2859000 | |
| CY2021Q3 | xene |
Accrued Consulting And Contracted Research Current
AccruedConsultingAndContractedResearchCurrent
|
3087000 | |
| CY2020Q4 | xene |
Accrued Consulting And Contracted Research Current
AccruedConsultingAndContractedResearchCurrent
|
4738000 | |
| CY2021Q3 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
387000 | |
| CY2020Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
167000 | |
| CY2021Q3 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
26000 | |
| CY2020Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
69000 | |
| CY2021Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
9968000 | |
| CY2020Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
10874000 | |
| CY2021Q1 | xene |
Warrants Exercise Description
WarrantsExerciseDescription
|
The Company may not affect the exercise of any Pre-Funded Warrant, and a holder will not be entitled to exercise any portion of any Pre-Funded Warrant that, upon giving effect to such exercise, would cause: (i) the aggregate number of common shares beneficially owned by such holder, together with its affiliates, to exceed 4.99% of the total number of common shares outstanding immediately after giving effect to the exercise; or (ii) the combined voting power of the Company’s securities beneficially owned by such holder, together with its affiliates, to exceed 4.99% of the combined voting power of all of the Company’s securities immediately outstanding after giving effect to the exercise, which percentage may be changed at the holder’s election to a higher or lower percentage not in excess of 19.99% upon at least 61 days’ notice to the Company. | |
| CY2021Q3 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
|
1081081 | |
| CY2021Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5771051 | |
| CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4595432 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
194400 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
1440050 | ||
| CY2021Q3 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
41974 | |
| CY2020Q3 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
375 | |
| us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
386708 | ||
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
3363 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
183505 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
34775 | ||
| CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5919434 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4786094 | |
| CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5919434 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4786094 | |
| CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
3068278 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
2324090 | |
| CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
3068278 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
2324090 | |
| xene |
Stock Options Exercised For Number Of Common Shares For Cash
StockOptionsExercisedForNumberOfCommonSharesForCash
|
61072 | ||
| xene |
Stock Options Exercised For Number Of Common Shares For Cash
StockOptionsExercisedForNumberOfCommonSharesForCash
|
10715 | ||
| xene |
Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
|
196206 | ||
| xene |
Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
|
85816 | ||
| xene |
Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
|
325636 | ||
| xene |
Cashless Exercise Of Stock Options
CashlessExerciseOfStockOptions
|
142702 | ||
| CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0100 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0040 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0116 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0072 | ||
| CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.68 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.68 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.68 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.68 | ||
| CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | |
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | ||
| us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0 | ||
| CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
10.74 | |
| CY2020Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
7.03 | |
| CY2021Q3 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
8124000 | |
| CY2020Q3 | us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
6554000 | |
| us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
14700000 | ||
| us-gaap |
Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
|
27016000 |
